Jingbo Hu

964 total citations
29 papers, 456 citations indexed

About

Jingbo Hu is a scholar working on Molecular Biology, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jingbo Hu has authored 29 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Nephrology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jingbo Hu's work include Acute Kidney Injury Research (7 papers), Diabetes Treatment and Management (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Jingbo Hu is often cited by papers focused on Acute Kidney Injury Research (7 papers), Diabetes Treatment and Management (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Jingbo Hu collaborates with scholars based in China, United States and Czechia. Jingbo Hu's co-authors include Xueying Tan, Jinhui Wang, Xiaoying Ying, Yongzhong Du, Yufen Zhao, Xiaoling Xu, Xu-Qi Kang, Saiping Jiang, Shujuan Li and Mary B. Chan‐Park and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release and Carbohydrate Polymers.

In The Last Decade

Jingbo Hu

27 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingbo Hu China 12 148 109 91 80 53 29 456
Yinhang Wang China 13 194 1.3× 61 0.6× 18 0.2× 26 0.3× 19 0.4× 26 471
Zhen Liang China 16 239 1.6× 59 0.5× 56 0.6× 34 0.4× 83 1.6× 41 681
Jianhua Li China 16 320 2.2× 85 0.8× 8 0.1× 39 0.5× 30 0.6× 31 873
Yakun Li China 17 193 1.3× 43 0.4× 41 0.5× 36 0.5× 55 1.0× 54 683
Chen Huang China 13 146 1.0× 55 0.5× 20 0.2× 28 0.3× 36 0.7× 50 459
Yanzhuo Liu China 18 502 3.4× 34 0.3× 42 0.5× 29 0.4× 39 0.7× 41 907
Alok Sharma India 13 147 1.0× 101 0.9× 35 0.4× 65 0.8× 51 1.0× 44 511
Yujuan Shi China 9 156 1.1× 72 0.7× 24 0.3× 59 0.7× 54 1.0× 26 410

Countries citing papers authored by Jingbo Hu

Since Specialization
Citations

This map shows the geographic impact of Jingbo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingbo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingbo Hu more than expected).

Fields of papers citing papers by Jingbo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingbo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingbo Hu. The network helps show where Jingbo Hu may publish in the future.

Co-authorship network of co-authors of Jingbo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingbo Hu. A scholar is included among the top collaborators of Jingbo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingbo Hu. Jingbo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jin, Jianbo, Jing Li, Hongbo Wang, Jingbo Hu, & Chun-Lin Yang. (2024). Engineering of VCAM-1-targeted nanostructured lipid carriers for delivery of melatonin against acute lung injury through SIRT1/NLRP3 mediated pyroptosis signaling pathway. International Journal of Biological Macromolecules. 266(Pt 1). 130637–130637. 5 indexed citations
3.
Lei, Kui, et al.. (2024). A mitochondrial targeted fluorescent probe for imaging nitroreductase activity and photodynamic therapy in tumor cells. Talanta. 285. 127392–127392. 3 indexed citations
4.
Wang, Jinhui, et al.. (2024). Engineering of phosphatidylserine-targeting ROS-responsive polymeric prodrug for the repair of ischemia-reperfusion-induced acute kidney injury. Journal of Controlled Release. 376. 1100–1114. 6 indexed citations
5.
Li, Yixuan, et al.. (2023). Engineering of targeting antioxidant polypeptide nanopolyplexes for the treatment of acute lung injury. International Journal of Biological Macromolecules. 254(Pt 3). 127872–127872. 3 indexed citations
7.
Wang, Hongbo, et al.. (2022). Enhanced efficiency of melatonin by stepwise-targeting strategy for acute lung injury. Frontiers in Bioengineering and Biotechnology. 10. 970743–970743. 3 indexed citations
8.
Li, Yixuan, et al.. (2022). Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases. Frontiers in Pharmacology. 13. 983816–983816. 15 indexed citations
9.
Zhang, Yujie, Xueying Tan, Jinhui Wang, et al.. (2021). A mitochondria-targeted dual-functional aggregation-induced emission luminogen for intracellular mitochondrial imaging and photodynamic therapy. Biomaterials Science. 9(4). 1232–1236. 16 indexed citations
10.
Zhang, Yujie, Xueying Tan, Nan Wang, et al.. (2021). An AIEgen-based photosensitizer for lysosome imaging and photodynamic therapy in tumor. Sensors and Actuators B Chemical. 335. 129698–129698. 24 indexed citations
11.
Peng, Jiejun, Hongze Liang, Yuwen Lu, et al.. (2021). Tumor Microenvironment Responsive Pepper Mild Mottle Virus-Based Nanotubes for Targeted Delivery and Controlled Release of Paclitaxel. Frontiers in Bioengineering and Biotechnology. 9. 763661–763661. 5 indexed citations
12.
Wang, Jinhui, Feifei Chen, Hui Jiang, et al.. (2021). Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method. Frontiers in Pharmacology. 11. 593518–593518. 9 indexed citations
13.
Wang, Jinhui, Shujuan Li, Xueying Tan, et al.. (2020). Engineering of stepwise-targeting chitosan oligosaccharide conjugate for the treatment of acute kidney injury. Carbohydrate Polymers. 256. 117556–117556. 49 indexed citations
14.
Li, Jianghua, Wenbin Zhong, Kaixi Zhang, et al.. (2020). Biguanide-Derived Polymeric Nanoparticles Kill MRSA Biofilm and Suppress Infection In Vivo. ACS Applied Materials & Interfaces. 12(19). 21231–21241. 59 indexed citations
15.
Hu, Jingbo, Chun-Lin Yang, Hongbo Wang, et al.. (2019). An up-to-date evaluation of alogliptin benzoate for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy. 20(14). 1679–1687. 2 indexed citations
16.
Hu, Jingbo, Min Wang, & Yufen Zhao. (2018). SAR342434 - an insulin biosimilar for the treatment of type II diabetes. Expert Opinion on Biological Therapy. 18(11). 1107–1112. 1 indexed citations
17.
Hu, Jingbo, Shujuan Li, Xu-Qi Kang, et al.. (2018). CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohydrate Polymers. 193. 268–280. 77 indexed citations
18.
Hu, Jingbo, Xu-Qi Kang, Jing Liang, et al.. (2017). E-selectin-targeted Sialic Acid-PEG-dexamethasone Micelles for Enhanced Anti-Inflammatory Efficacy for Acute Kidney Injury. Theranostics. 7(8). 2204–2219. 64 indexed citations
19.
Tan, Xueying & Jingbo Hu. (2016). Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy. 17(9). 1285–1293. 25 indexed citations
20.
Hu, Jingbo, Yan Zhou, Dandan Jiang, & Wen‐Song Tan. (2006). [Proliferation and differentiation characteristics of human bone marrow mesenchymal stem cells during ex-vivo expansion].. PubMed. 22(1). 7–10. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026